MM-183 CARTITUDE-2 Cohort A: Updated Clinical Data and Biological Correlative Analyses of Ciltacabtagene Autoleucel (cilta-cel) in Lenalidomide-Refractory Patients With Progressive Multiple Myeloma (MM) After 1–3 Prior Lines of Therapy (LOT)

Authors:
  • JHJens Hillengass
    Jens Hillengass
  • ACAdam D Cohen
    Adam D Cohen
  • MDMichel Delforge
    Michel Delforge
  • HEHermann Einsele
    Hermann Einsele
  • HGHartmut Goldschmidt
    Hartmut Goldschmidt
  • KWKatja Weisel
    Katja Weisel
  • MRMarc-Steffen Raab
    Marc-Steffen Raab
  • CSChristof Scheid
    Christof Scheid
  • JSJordan M Schecter
    Jordan M Schecter
  • KBKevin C de Braganca
    Kevin C de Braganca
  • HVHelen Varsos
    Helen Varsos
  • TYTzu-Min Yeh
    Tzu-Min Yeh

Abstract
No abstract available